Yoshimura, A., Yamada, T., Serizawa, M., Uehara, H., Tanimura, K., Okuma, Y., Fukuda, A., Watanabe, S., Nishioka, N., Takeda, T., Chihara, Y., Takemoto, S., Harada, T., Hiranuma, O., Shirai, Y., Shukuya, T., Nishiyama, A., Goto, Y., Shiotsu, S., Kunimasa, K., Morimoto, K., Katayama, Y., Suda, K., Mitsudomi, T., Yano, S., Kenmotsu, H., Takahashi, T., & Takayama, K. (2023). high levels of AXL expression in untreated EGFR‐mutated non‐small cell lung cancer negatively impacts the use of osimertinib. Cancer science, 114(2), 606–618. http://access.bl.uk/ark:/81055/vdc_100177547163.0x000027